vs

Side-by-side financial comparison of Nuvalent, Inc. (NUVL) and Valaris Ltd (VAL). Click either name above to swap in a different company.

Nuvalent, Inc. is the larger business by last-quarter revenue ($8.7M vs $5.2M, roughly 1.7× Valaris Ltd). Valaris Ltd runs the higher net margin — 13798.1% vs -969.5%, a 14767.6% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs 74.0%).

Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted precision therapies for cancer patients. The firm designs novel molecules to address unmet needs in solid tumor treatment, targeting specific genetic mutations that drive cancer growth, with multiple oncology pipeline candidates advancing through clinical development for global markets.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

NUVL vs VAL — Head-to-Head

Bigger by revenue
NUVL
NUVL
1.7× larger
NUVL
$8.7M
$5.2M
VAL
Growing faster (revenue YoY)
VAL
VAL
+331.9% gap
VAL
405.9%
74.0%
NUVL
Higher net margin
VAL
VAL
14767.6% more per $
VAL
13798.1%
-969.5%
NUVL

Income Statement — Q3 FY2024 vs Q4 FY2025

Metric
NUVL
NUVL
VAL
VAL
Revenue
$8.7M
$5.2M
Net Profit
$-84.3M
$717.5M
Gross Margin
-7850.0%
Operating Margin
-877.4%
Net Margin
-969.5%
13798.1%
Revenue YoY
74.0%
405.9%
Net Profit YoY
-150.7%
436.6%
EPS (diluted)
$-1.28
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUVL
NUVL
VAL
VAL
Q4 25
$5.2M
Q3 25
$5.6M
Q2 25
$700.0K
Q4 24
$-1.7M
Q3 24
$8.7M
$3.9M
Q2 24
$8.1M
$4.8M
Q1 24
$8.5M
$2.6M
Q4 23
$3.1M
Net Profit
NUVL
NUVL
VAL
VAL
Q4 25
$717.5M
Q3 25
$188.1M
Q2 25
$115.1M
Q4 24
$133.7M
Q3 24
$-84.3M
$64.6M
Q2 24
$-57.2M
$149.6M
Q1 24
$-44.5M
$25.5M
Q4 23
$828.5M
Gross Margin
NUVL
NUVL
VAL
VAL
Q4 25
-7850.0%
Q3 25
-7142.9%
Q2 25
-56428.6%
Q4 24
24529.4%
Q3 24
-11748.7%
Q2 24
-9039.6%
Q1 24
-17007.7%
Q4 23
-12867.7%
Operating Margin
NUVL
NUVL
VAL
VAL
Q4 25
Q3 25
Q2 25
Q4 24
Q3 24
-877.4%
Q2 24
-804.3%
Q1 24
-618.7%
Q4 23
Net Margin
NUVL
NUVL
VAL
VAL
Q4 25
13798.1%
Q3 25
3358.9%
Q2 25
16442.9%
Q4 24
-7864.7%
Q3 24
-969.5%
1656.4%
Q2 24
-705.8%
3116.7%
Q1 24
-523.3%
980.8%
Q4 23
26725.8%
EPS (diluted)
NUVL
NUVL
VAL
VAL
Q4 25
$10.13
Q3 25
$2.65
Q2 25
$1.61
Q4 24
$1.86
Q3 24
$-1.28
$0.88
Q2 24
$-0.88
$2.03
Q1 24
$-0.69
$0.35
Q4 23
$11.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUVL
NUVL
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$1.2B
$599.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$3.2B
Total Assets
$1.2B
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUVL
NUVL
VAL
VAL
Q4 25
$599.4M
Q3 25
$662.7M
Q2 25
$503.4M
Q4 24
$368.2M
Q3 24
$1.2B
$379.3M
Q2 24
$658.0M
$398.3M
Q1 24
$691.8M
$494.1M
Q4 23
$620.5M
Stockholders' Equity
NUVL
NUVL
VAL
VAL
Q4 25
$3.2B
Q3 25
$2.4B
Q2 25
$2.3B
Q4 24
$2.2B
Q3 24
$1.1B
$2.1B
Q2 24
$637.0M
$2.2B
Q1 24
$675.0M
$2.0B
Q4 23
$2.0B
Total Assets
NUVL
NUVL
VAL
VAL
Q4 25
$5.3B
Q3 25
$4.6B
Q2 25
$4.5B
Q4 24
$4.4B
Q3 24
$1.2B
$4.3B
Q2 24
$675.2M
$4.4B
Q1 24
$708.5M
$4.4B
Q4 23
$4.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUVL
NUVL
VAL
VAL
Operating Cash FlowLast quarter
$-45.8M
$72.2M
Free Cash FlowOCF − Capex
$-34.1M
FCF MarginFCF / Revenue
-655.8%
Capex IntensityCapex / Revenue
2044.2%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUVL
NUVL
VAL
VAL
Q4 25
$72.2M
Q3 25
$198.1M
Q2 25
$120.0M
Q4 24
$124.6M
Q3 24
$-45.8M
$193.0M
Q2 24
$-41.2M
$11.5M
Q1 24
$-36.1M
$26.3M
Q4 23
$96.7M
Free Cash Flow
NUVL
NUVL
VAL
VAL
Q4 25
$-34.1M
Q3 25
$128.3M
Q2 25
$52.8M
Q4 24
$12.9M
Q3 24
$111.1M
Q2 24
$-98.7M
Q1 24
$-125.0M
Q4 23
$-366.3M
FCF Margin
NUVL
NUVL
VAL
VAL
Q4 25
-655.8%
Q3 25
2291.1%
Q2 25
7542.9%
Q4 24
-758.8%
Q3 24
2848.7%
Q2 24
-2056.3%
Q1 24
-4807.7%
Q4 23
-11816.1%
Capex Intensity
NUVL
NUVL
VAL
VAL
Q4 25
2044.2%
Q3 25
1246.4%
Q2 25
9600.0%
Q4 24
-6570.6%
Q3 24
2100.0%
Q2 24
2295.8%
Q1 24
5819.2%
Q4 23
14935.5%
Cash Conversion
NUVL
NUVL
VAL
VAL
Q4 25
0.10×
Q3 25
1.05×
Q2 25
1.04×
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×
Q4 23
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons